EUVIMEDEUVIMED entdecken
Vergleichsstudie

Incidence of Thrombocytopenia With Different Continuous Renal Replacement Systems and Modalities in a Cardiac Intensive Care Unit

Jessica C Brumit iD, Ryan A Caputo, Sheila M Chucta, Rachel M Smith, Samantha Warren, Kevin T Kissling

Journal of Pharmacy Practice · 2025

DOI: 10.1177/08971900241302388 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Jessica C Brumit und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Thrombocytopenia, Continuous Renal Replacement Therapy, Intensive Care Units, Coronary Care Units. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Center for Advancing Translational Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thrombocytopenia is due to multifactorial causes in critically ill patients. One etiology is continuous renal replacement therapy (CRRT); however, it is unknown if different modalities impact the incidence.

Objectives

To compare the incidence of thrombocytopenia with the NxStage CRRT system using continuous venovenous hemodialysis (CVVHD) compared to the Prismaflex system using continuous venovenous hemodiafiltration (CVVHDF).

Methods

This was a retrospective cohort study at a large academic medical center in the United States. Individuals aged 18 or older admitted to the cardiovascular ICU between June 1, 2016 and September 30, 2022, and received CRRT for at least 48 hours were identified.

Results

One hundred and forty-seven patients met inclusion criteria. Sixty-one patients received CVVHD with the NxStage system, while 86 received CVVHDF with the Prismaflex system. Thrombocytopenia occurred in 57.4% of patients treated with NxStage vs 19.8% treated with Prismaflex (OR 5.46; 95% confidence interval [CI], 2.62-11.39). These results were consistent in an adjusted model (OR 5.57; 95% CI, 2.34-13.28). There was no difference in the time to thrombocytopenia between groups. Patients treated with the NxStage system had lower platelet nadirs, more heparin-induced thrombocytopenia testing, more direct thrombin inhibitor use, and more blood transfusions.

Conclusions

A greater incidence of thrombocytopenia occurred in cardiovascular ICU patients treated with CVVHD using the NxStage system vs CVVHDF with the Prismaflex system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaContinuous Renal Replacement TherapyIntensive Care UnitsCoronary Care UnitsHumansRetrospective StudiesMaleFemaleMiddle AgedIncidenceAgedCohort StudiesCritical Illness

Stichwörter der Autor:innen

continuous renal replacement therapyheparin-induced thrombocytopeniathrombocytopenia

Autor:innen und Institutionen

  • Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Department of Pharmacy, Indiana University Health Methodist Hospital, Indianapolis, IN, USA.
  • Center of Quality and Education, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
  • Department of Nursing, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

ORCID-Profile: Jessica C Brumit

Förderung

  • National Center for Advancing Translational Sciences of the National Institutes of Health

Zitieren

APA

Brumit, J. C., Caputo, R. A., Chucta, S. M., Smith, R. M., Warren, S., & Kissling, K. T. (2025). Incidence of Thrombocytopenia With Different Continuous Renal Replacement Systems and Modalities in a Cardiac Intensive Care Unit. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241302388

Vancouver

Brumit JC, Caputo RA, Chucta SM, Smith RM, Warren S, Kissling KT. Incidence of Thrombocytopenia With Different Continuous Renal Replacement Systems and Modalities in a Cardiac Intensive Care Unit. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900241302388

BibTeX
@article{Brumit2025,
  author = {Brumit, Jessica C and Caputo, Ryan A and Chucta, Sheila M and Smith, Rachel M and Warren, Samantha and Kissling, Kevin T},
  title = {Incidence of Thrombocytopenia With Different Continuous Renal Replacement Systems and Modalities in a Cardiac Intensive Care Unit},
  journal = {Journal of Pharmacy Practice},
  year = {2025},
  doi = {10.1177/08971900241302388}
}
Kostenlos starten →